Ruxolitinib combined with chemotherapy can eradicate chemorefractory central nervous system acute lymphoblastic leukaemia

Br J Haematol. 2019 Oct;187(1):e24-e27. doi: 10.1111/bjh.16142. Epub 2019 Aug 5.
No abstract available

Keywords: acute lymphoblastic leukaemia; central nervous system; chemotherapy; intrathecal; ruxolitinib.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Apoptosis / drug effects
  • Coculture Techniques
  • Female
  • Humans
  • Meningeal Neoplasms / drug therapy*
  • Meninges / cytology
  • Nitriles
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Pyrazoles / administration & dosage
  • Pyrazoles / pharmacology
  • Pyrimidines
  • Tumor Cells, Cultured

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib